Myriad Genetics, Inc. (MYGN)
4.745
+0.08
(+1.61%)
USD |
NASDAQ |
Apr 07, 16:00
4.745
0.00 (0.00%)
After-Hours: 17:35
Myriad Genetics Market Cap : 443.70M for April 7, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 176.91B |
| Enovis Corp. | 1.291B |
| Pacific Biosciences of California, Inc. | 436.39M |
| Tandem Diabetes Care, Inc. | 1.248B |
| iRhythm Holdings, Inc. | 3.833B |
Market Cap Related Metrics
| PS Ratio | 0.5237 |
| PEG Ratio | -0.0065 |
| Price to Book Value | 1.185 |
| Price | 4.745 |
| Earnings Yield | -84.74% |
| PEGY Ratio | -0.0065 |